Commentary
In this review, D. Toobian et al. (University of California San Diego, CA, USA) underline emerging evidence of the potential roles of the PPAR subtypes in macrophage biology.
They also discuss the roles of dual and pan PPAR agonists as modulators of immune cell function, microbial infection, and inflammatory diseases.
Previous Post
AGA: a NAFLD clinical care pathway
Next Post
Fatty liver through the ages: Nonalcoholic steatohepatitis